Stay updated on All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Sign up to get notified when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.

Latest updates to the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page displays a newer site revision identifier, changing from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” no longer appears. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology, while the study page remains an error page.SummaryDifference1%

- Check36 days agoChange DetectedThe 403 Forbidden page's footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.